# Walker & Dunlop, Inc.: financial statements, quarterly

WD · NYSE · CIK 1497770 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wd.md) · [Financials](/companies/wd/financials.md) · [Filings](/companies/wd/filings.md) · [Insiders](/companies/wd/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wd/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [61.6](/filings/0001558370-24-014739.md) | [67.0 d](/filings/0001104659-26-020249.md) | [52.4](/filings/0001558370-25-006483.md) | [68.4](/filings/0001558370-25-010622.md) | [64.4](/filings/0001104659-25-107312.md) | [80.2 d](/filings/0001104659-26-020249.md) | [58.0](/filings/0001104659-26-056572.md) | [77.7](/filings/0001104659-26-091536.md) | [76.5](/filings/0001104659-25-107312.md) | [108 d](/filings/0001104659-26-020249.md) | [71.5](/filings/0001104659-26-056572.md) | [82.4](/filings/0001104659-26-091536.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [13.9](/filings/0001558370-23-018399.md) | [12.8 d](/filings/0001558370-24-001538.md) | [8.6](/filings/0001558370-24-006445.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [7.1](/filings/0001558370-24-014739.md) | [10.3 d](/filings/0001104659-26-020249.md) | [2.9](/filings/0001558370-25-006483.md) | [7.9](/filings/0001558370-25-010622.md) | [8.8](/filings/0001104659-25-107312.md) | [11.0 d](/filings/0001104659-26-020249.md) | [2.5](/filings/0001104659-26-056572.md) | [12.4](/filings/0001104659-26-091536.md) | [12.5](/filings/0001104659-25-107312.md) | [(5.4) d](/filings/0001104659-26-020249.md) | [8.0](/filings/0001104659-26-056572.md) | [(0.8)](/filings/0001104659-26-091536.md) |
| Net income | $m | [21.5](/filings/0001558370-24-014739.md) | [31.6 d](/filings/0001104659-26-020249.md) | [11.9](/filings/0001104659-25-107312.md) | [22.7](/filings/0001104659-25-107312.md) | [28.8](/filings/0001104659-25-107312.md) | [44.8 d](/filings/0001104659-26-020249.md) | [2.8](/filings/0001104659-26-091536.md) | [34.0](/filings/0001104659-26-091536.md) | [33.5](/filings/0001104659-25-107312.md) | [(13.9) d](/filings/0001104659-26-020249.md) | [15.9](/filings/0001104659-26-091536.md) | [3.0](/filings/0001104659-26-091536.md) |
| Diluted EPS | $ per share | [0.64](/filings/0001558370-24-014739.md) | not reported | [0.35](/filings/0001558370-25-006483.md) | [0.67](/filings/0001558370-25-010622.md) | [0.85](/filings/0001104659-25-107312.md) | not reported | [0.08](/filings/0001104659-26-056572.md) | [0.99](/filings/0001104659-26-091536.md) | [0.98](/filings/0001104659-25-107312.md) | not reported | [0.46](/filings/0001104659-26-056572.md) | [0.09](/filings/0001104659-26-091536.md) |
| Basic EPS | $ per share | [0.64](/filings/0001558370-24-014739.md) | not reported | [0.35](/filings/0001558370-25-006483.md) | [0.67](/filings/0001558370-25-010622.md) | [0.85](/filings/0001104659-25-107312.md) | not reported | [0.08](/filings/0001104659-26-056572.md) | [1.00](/filings/0001104659-26-091536.md) | [0.98](/filings/0001104659-25-107312.md) | not reported | [0.46](/filings/0001104659-26-056572.md) | [0.09](/filings/0001104659-26-091536.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [236](/filings/0001558370-24-014739.md) | [329](/filings/0001104659-26-020249.md) | [217](/filings/0001558370-25-006483.md) | [208](/filings/0001558370-25-010622.md) | [180](/filings/0001104659-25-107312.md) | [279](/filings/0001104659-26-091536.md) | [181](/filings/0001104659-26-056572.md) | [234](/filings/0001104659-26-091536.md) | [275](/filings/0001104659-25-107312.md) | [299](/filings/0001104659-26-091536.md) | [193](/filings/0001104659-26-056572.md) | [161](/filings/0001104659-26-091536.md) |
| Total assets | $m | [4,278](/filings/0001558370-24-014739.md) | [4,052](/filings/0001104659-26-020249.md) | [3,826](/filings/0001558370-25-006483.md) | [4,175](/filings/0001558370-25-010622.md) | [4,579](/filings/0001104659-25-107312.md) | [4,382](/filings/0001104659-26-020249.md) | [4,512](/filings/0001104659-26-056572.md) | [4,675](/filings/0001104659-26-091536.md) | [5,797](/filings/0001104659-25-107312.md) | [5,059](/filings/0001104659-26-091536.md) | [6,165](/filings/0001104659-26-056572.md) | [4,894](/filings/0001104659-26-091536.md) |
| Total liabilities | $m | [2,547](/filings/0001558370-23-018399.md) | [2,306](/filings/0001558370-25-001503.md) | [2,090](/filings/0001558370-24-006445.md) | [2,442](/filings/0001558370-24-011457.md) | [2,833](/filings/0001558370-24-014739.md) | [2,622](/filings/0001104659-26-020249.md) | [2,768](/filings/0001558370-25-006483.md) | [2,913](/filings/0001558370-25-010622.md) | [4,020](/filings/0001104659-25-107312.md) | [3,314](/filings/0001104659-26-091536.md) | [4,432](/filings/0001104659-26-056572.md) | [3,173](/filings/0001104659-26-091536.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,706](/filings/0001558370-23-018399.md) | [1,724](/filings/0001558370-25-001503.md) | [1,715](/filings/0001558370-24-006445.md) | [1,697](/filings/0001558370-24-011457.md) | [1,710](/filings/0001558370-24-014739.md) | [1,748](/filings/0001104659-26-020249.md) | [1,732](/filings/0001558370-25-006483.md) | [1,750](/filings/0001558370-25-010622.md) | [1,766](/filings/0001104659-25-107312.md) | [1,735](/filings/0001104659-26-091536.md) | [1,720](/filings/0001104659-26-056572.md) | [1,707](/filings/0001104659-26-091536.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [549 d](/filings/0001558370-24-014739.md) | [332 d](/filings/0001104659-26-020249.md) | [38.4](/filings/0001558370-25-006483.md) | [(238) d](/filings/0001558370-25-010622.md) | [(202) d](/filings/0001104659-25-107312.md) | [531 d](/filings/0001104659-26-020249.md) | [(281)](/filings/0001104659-26-056572.md) | [(238) d](/filings/0001104659-26-091536.md) | [(948) d](/filings/0001104659-25-107312.md) | [803 d](/filings/0001104659-26-020249.md) | [(1,144)](/filings/0001104659-26-056572.md) | [1,169 d](/filings/0001104659-26-091536.md) |
| Capital expenditure | $m | [4.4 d](/filings/0001558370-24-014739.md) | [2.3 d](/filings/0001104659-26-020249.md) | [3.2](/filings/0001558370-25-006483.md) | [3.8 d](/filings/0001558370-25-010622.md) | [2.0 d](/filings/0001104659-25-107312.md) | [3.9 d](/filings/0001104659-26-020249.md) | [3.6](/filings/0001104659-26-056572.md) | [2.6 d](/filings/0001104659-26-091536.md) | [2.3 d](/filings/0001104659-25-107312.md) | [7.3 d](/filings/0001104659-26-020249.md) | [1.9](/filings/0001104659-26-056572.md) | [0.6 d](/filings/0001104659-26-091536.md) |
| Dividends paid | $m | [21.1 d](/filings/0001558370-24-014739.md) | [21.3 d](/filings/0001104659-26-020249.md) | [22.0](/filings/0001558370-25-006483.md) | [22.2 d](/filings/0001558370-25-010622.md) | [22.1 d](/filings/0001104659-25-107312.md) | [22.4 d](/filings/0001104659-26-020249.md) | [22.9](/filings/0001104659-26-056572.md) | [22.9 d](/filings/0001104659-26-091536.md) | [23.0 d](/filings/0001104659-25-107312.md) | [23.0 d](/filings/0001104659-26-020249.md) | [23.6](/filings/0001104659-26-056572.md) | [23.6 d](/filings/0001104659-26-091536.md) |
| Share repurchases | $m | [0.9 d](/filings/0001558370-24-014739.md) | [1.6 d](/filings/0001104659-26-020249.md) | [9.8](/filings/0001558370-25-006483.md) | [0.8 d](/filings/0001558370-25-010622.md) | [1.4 d](/filings/0001104659-25-107312.md) | [0.4 d](/filings/0001104659-26-020249.md) | [8.6](/filings/0001104659-26-056572.md) | [0.6 d](/filings/0001104659-26-091536.md) | [1.0 d](/filings/0001104659-25-107312.md) | [0.2 d](/filings/0001104659-26-020249.md) | [19.1](/filings/0001104659-26-056572.md) | [0.3 d](/filings/0001104659-26-091536.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [32.6](/filings/0001558370-23-018399.md) | [32.8](/filings/0001558370-24-006445.md) | [32.9](/filings/0001558370-24-011457.md) | [32.9](/filings/0001558370-24-014739.md) | [33.0](/filings/0001558370-25-006483.md) | [33.2](/filings/0001558370-25-010622.md) | [33.2](/filings/0001104659-25-107312.md) | [33.3](/filings/0001104659-26-056572.md) | [33.4](/filings/0001104659-26-091536.md) | [33.4](/filings/0001104659-25-107312.md) | [33.4](/filings/0001104659-26-056572.md) | [33.3](/filings/0001104659-26-091536.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 34,325,745 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001104659-26-091536.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.